Shuang Wu, Xu Yang, Yang Chen, Yimeng Wang, Hanyang Liang, Wei Xu, Juan Wang, Xinghui Shao, Han Zhang, Ziyi Zhong, Hongyu Liu, Bi Huang, Siqi Lyu, Lihui Zheng
{"title":"抑郁症状的变化作为心血管疾病发生的预测因素:来自四个前瞻性队列的见解","authors":"Shuang Wu, Xu Yang, Yang Chen, Yimeng Wang, Hanyang Liang, Wei Xu, Juan Wang, Xinghui Shao, Han Zhang, Ziyi Zhong, Hongyu Liu, Bi Huang, Siqi Lyu, Lihui Zheng","doi":"10.1093/eurjpc/zwaf586","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>This study examines how changes in depressive symptoms influence cardiovascular disease (CVD) incidence in diverse aging populations.</p><p><strong>Methods and results: </strong>Data from four longitudinal cohorts were harmonized: CHARLS (China), ELSA (UK), HRS (US), and MHAS (Mexico). Depressive symptoms were assessed at baseline and follow-up using validated scales, and scores were standardized using z-scores. The primary outcome was incident CVD, defined as a composite of heart attack, angina, congestive heart failure, other physician-diagnosed heart conditions, and stroke. Cox proportional regression analyses assessed the associations between changes in depressive symptoms and CVD risk. Progression from no depression to mild depression was associated with a 28% increase in CVD risk (95% CI: 1.14-1.44), while progression to moderate-to-severe depression was associated with a 23% increase (95% CI: 1.04-1.46). Conversely, remission from mild depression to no depression significantly reduced CVD risk by 19% (95% CI: 0.68-0.98). Improvement from moderate-to-severe depression to mild depression decreased CVD risk by 25% (95% CI: 0.61-0.93), and remission from moderate-to-severe depression to no depression reduced it by 38% (95% CI: 0.50-0.76). Each 1-unit increase in the total depression score raised CVD risk by 12% (95% CI: 1.10-1.14), while each 1-unit increase in depression score change increased risk by 15% (95% CI: 1.11-1.19). Effects were stronger in participants aged <65 years than participants aged ≥65 years.</p><p><strong>Conclusion: </strong>This multinational cohort study demonstrates that worsening or progression of depressive symptoms increases CVD risk, while remission or improvement confers protective effects, highlighting the need to monitor depression symptom changes in CVD prevention.</p>","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in depressive symptoms as predictors of incident cardiovascular disease: insights from four prospective cohorts.\",\"authors\":\"Shuang Wu, Xu Yang, Yang Chen, Yimeng Wang, Hanyang Liang, Wei Xu, Juan Wang, Xinghui Shao, Han Zhang, Ziyi Zhong, Hongyu Liu, Bi Huang, Siqi Lyu, Lihui Zheng\",\"doi\":\"10.1093/eurjpc/zwaf586\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>This study examines how changes in depressive symptoms influence cardiovascular disease (CVD) incidence in diverse aging populations.</p><p><strong>Methods and results: </strong>Data from four longitudinal cohorts were harmonized: CHARLS (China), ELSA (UK), HRS (US), and MHAS (Mexico). Depressive symptoms were assessed at baseline and follow-up using validated scales, and scores were standardized using z-scores. The primary outcome was incident CVD, defined as a composite of heart attack, angina, congestive heart failure, other physician-diagnosed heart conditions, and stroke. Cox proportional regression analyses assessed the associations between changes in depressive symptoms and CVD risk. Progression from no depression to mild depression was associated with a 28% increase in CVD risk (95% CI: 1.14-1.44), while progression to moderate-to-severe depression was associated with a 23% increase (95% CI: 1.04-1.46). Conversely, remission from mild depression to no depression significantly reduced CVD risk by 19% (95% CI: 0.68-0.98). Improvement from moderate-to-severe depression to mild depression decreased CVD risk by 25% (95% CI: 0.61-0.93), and remission from moderate-to-severe depression to no depression reduced it by 38% (95% CI: 0.50-0.76). Each 1-unit increase in the total depression score raised CVD risk by 12% (95% CI: 1.10-1.14), while each 1-unit increase in depression score change increased risk by 15% (95% CI: 1.11-1.19). Effects were stronger in participants aged <65 years than participants aged ≥65 years.</p><p><strong>Conclusion: </strong>This multinational cohort study demonstrates that worsening or progression of depressive symptoms increases CVD risk, while remission or improvement confers protective effects, highlighting the need to monitor depression symptom changes in CVD prevention.</p>\",\"PeriodicalId\":12051,\"journal\":{\"name\":\"European journal of preventive cardiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of preventive cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/eurjpc/zwaf586\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of preventive cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurjpc/zwaf586","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Changes in depressive symptoms as predictors of incident cardiovascular disease: insights from four prospective cohorts.
Aims: This study examines how changes in depressive symptoms influence cardiovascular disease (CVD) incidence in diverse aging populations.
Methods and results: Data from four longitudinal cohorts were harmonized: CHARLS (China), ELSA (UK), HRS (US), and MHAS (Mexico). Depressive symptoms were assessed at baseline and follow-up using validated scales, and scores were standardized using z-scores. The primary outcome was incident CVD, defined as a composite of heart attack, angina, congestive heart failure, other physician-diagnosed heart conditions, and stroke. Cox proportional regression analyses assessed the associations between changes in depressive symptoms and CVD risk. Progression from no depression to mild depression was associated with a 28% increase in CVD risk (95% CI: 1.14-1.44), while progression to moderate-to-severe depression was associated with a 23% increase (95% CI: 1.04-1.46). Conversely, remission from mild depression to no depression significantly reduced CVD risk by 19% (95% CI: 0.68-0.98). Improvement from moderate-to-severe depression to mild depression decreased CVD risk by 25% (95% CI: 0.61-0.93), and remission from moderate-to-severe depression to no depression reduced it by 38% (95% CI: 0.50-0.76). Each 1-unit increase in the total depression score raised CVD risk by 12% (95% CI: 1.10-1.14), while each 1-unit increase in depression score change increased risk by 15% (95% CI: 1.11-1.19). Effects were stronger in participants aged <65 years than participants aged ≥65 years.
Conclusion: This multinational cohort study demonstrates that worsening or progression of depressive symptoms increases CVD risk, while remission or improvement confers protective effects, highlighting the need to monitor depression symptom changes in CVD prevention.
期刊介绍:
European Journal of Preventive Cardiology (EJPC) is an official journal of the European Society of Cardiology (ESC) and the European Association of Preventive Cardiology (EAPC). The journal covers a wide range of scientific, clinical, and public health disciplines related to cardiovascular disease prevention, risk factor management, cardiovascular rehabilitation, population science and public health, and exercise physiology. The categories covered by the journal include classical risk factors and treatment, lifestyle risk factors, non-modifiable cardiovascular risk factors, cardiovascular conditions, concomitant pathological conditions, sport cardiology, diagnostic tests, care settings, epidemiology, pharmacology and pharmacotherapy, machine learning, and artificial intelligence.